June 24, 2025

AstraZeneca and Daiichi Sankyo’s Datroway Approved to Treat Non-Small Cell Lung Cancer in U.S. – WSJ

June 24, 2025

AZ, Daiichi’s Datroway scores its 2nd FDA approval—this time in lung cancer subset – Fierce Pharma

June 24, 2025

FDA Grants Label Expansion to AstraZeneca’s Datroway in Lung Cancer – Yahoo Finance

June 23, 2025

ArriVent reports 16-month progression-free survival for lung cancer drug – Investing.com

June 23, 2025

Two-in-one treatment targets ‘undruggable’ lung cancer – UIC today